Literature DB >> 27467440

Association Between Germline Mutation in VSIG10L and Familial Barrett Neoplasia.

Ryan E Fecteau1, Jianping Kong2, Adam Kresak1, Wendy Brock3, Yeunjoo Song4, Hisashi Fujioka5, Robert Elston6, Joseph E Willis7, John P Lynch2, Sanford D Markowitz8, Kishore Guda9, Amitabh Chak10.   

Abstract

IMPORTANCE: Esophageal adenocarcinoma and its precursor lesion Barrett esophagus have seen a dramatic increase in incidence over the past 4 decades yet marked genetic heterogeneity of this disease has precluded advances in understanding its pathogenesis and improving treatment.
OBJECTIVE: To identify novel disease susceptibility variants in a familial syndrome of esophageal adenocarcinoma and Barrett esophagus, termed familial Barrett esophagus, by using high-throughput sequencing in affected individuals from a large, multigenerational family. DESIGN, SETTING, AND PARTICIPANTS: We performed whole exome sequencing (WES) from peripheral lymphocyte DNA on 4 distant relatives from our multiplex, multigenerational familial Barrett esophagus family to identify candidate disease susceptibility variants. Gene variants were filtered, verified, and segregation analysis performed to identify a single candidate variant. Gene expression analysis was done with both quantitative real-time polymerase chain reaction and in situ RNA hybridization. A 3-dimensional organotypic cell culture model of esophageal maturation was utilized to determine the phenotypic effects of our gene variant. We used electron microscopy on esophageal mucosa from an affected family member carrying the gene variant to assess ultrastructural changes. MAIN OUTCOMES AND MEASURES: Identification of a novel, germline disease susceptibility variant in a previously uncharacterized gene.
RESULTS: A multiplex, multigenerational family with 14 members affected (3 members with esophageal adenocarcinoma and 11 with Barrett esophagus) was identified, and whole-exome sequencing identified a germline mutation (S631G) at a highly conserved serine residue in the uncharacterized gene VSIG10L that segregated in affected members. Transfection of S631G variant into a 3-dimensional organotypic culture model of normal esophageal squamous cells dramatically inhibited epithelial maturation compared with the wild-type. VSIG10L exhibited high expression in normal squamous esophagus with marked loss of expression in Barrett-associated lesions. Electron microscopy of squamous esophageal mucosa harboring the S631G variant revealed dilated intercellular spaces and reduced desmosomes. CONCLUSIONS AND RELEVANCE: This study presents VSIG10L as a candidate familial Barrett esophagus susceptibility gene, with a putative role in maintaining normal esophageal homeostasis. Further research assessing VSIG10L function may reveal pathways important for esophageal maturation and the pathogenesis of Barrett esophagus and esophageal adenocarcinoma.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27467440      PMCID: PMC5063702          DOI: 10.1001/jamaoncol.2016.2054

Source DB:  PubMed          Journal:  JAMA Oncol        ISSN: 2374-2437            Impact factor:   31.777


  15 in total

1.  Esophageal adenocarcinoma incidence: are we reaching the peak?

Authors:  Heiko Pohl; Brenda Sirovich; H Gilbert Welch
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-05-25       Impact factor: 4.254

2.  Dilated intercellular spaces of esophageal epithelium in nonerosive reflux disease patients with physiological esophageal acid exposure.

Authors:  Renato Caviglia; Mentore Ribolsi; Nicola Maggiano; Armando M Gabbrielli; Sara Emerenziani; Michele Pier Luca Guarino; Simone Carotti; Fortunéé Irene Habib; Carla Rabitti; Michele Cicala
Journal:  Am J Gastroenterol       Date:  2005-03       Impact factor: 10.864

3.  Dilated intercellular spaces: a morphological feature of acid reflux--damaged human esophageal epithelium.

Authors:  N A Tobey; J L Carson; R A Alkiek; R C Orlando
Journal:  Gastroenterology       Date:  1996-11       Impact factor: 22.682

4.  Germline mutations in MSR1, ASCC1, and CTHRC1 in patients with Barrett esophagus and esophageal adenocarcinoma.

Authors:  Mohammed Orloff; Charissa Peterson; Xin He; Shireen Ganapathi; Brandie Heald; Yi-ran Yang; Gurkan Bebek; Todd Romigh; Jee Hoon Song; Wenjing Wu; Stefan David; Yulan Cheng; Stephen J Meltzer; Charis Eng
Journal:  JAMA       Date:  2011-07-27       Impact factor: 56.272

5.  Identification of Barrett's esophagus in relatives by endoscopic screening.

Authors:  Amitabh Chak; Ashley Faulx; Margaret Kinnard; Wendy Brock; Joseph Willis; Georgia L Wiesner; Antonio R Parrado; Katrina A B Goddard
Journal:  Am J Gastroenterol       Date:  2004-11       Impact factor: 10.864

6.  Reversibility of GERD ultrastructural alterations and relief of symptoms after omeprazole treatment.

Authors:  Carlo Calabrese; Mauro Bortolotti; Anna Fabbri; Alessandra Areni; Giovanna Cenacchi; Carlo Scialpi; Mario Miglioli; Giulio Di Febo
Journal:  Am J Gastroenterol       Date:  2005-03       Impact factor: 10.864

7.  Barrett's esophagus. A prevalent, occult complication of gastroesophageal reflux disease.

Authors:  C Winters; T J Spurling; S J Chobanian; D J Curtis; R L Esposito; J F Hacker; D A Johnson; D F Cruess; J D Cotelingam; M S Gurney
Journal:  Gastroenterology       Date:  1987-01       Impact factor: 22.682

8.  ACG Clinical Guideline: Diagnosis and Management of Barrett's Esophagus.

Authors:  Nicholas J Shaheen; Gary W Falk; Prasad G Iyer; Lauren B Gerson
Journal:  Am J Gastroenterol       Date:  2015-11-03       Impact factor: 10.864

9.  Barrett's esophagus: review of diagnosis and treatment.

Authors:  Raja Shekhar Sappati Biyyani; Amithab Chak
Journal:  Gastroenterol Rep (Oxf)       Date:  2013-04-30

10.  A genome-wide association study identifies new susceptibility loci for esophageal adenocarcinoma and Barrett's esophagus.

Authors:  David M Levine; Weronica E Ek; Rui Zhang; Xinxue Liu; Lynn Onstad; Cassandra Sather; Pierre Lao-Sirieix; Marilie D Gammon; Douglas A Corley; Nicholas J Shaheen; Nigel C Bird; Laura J Hardie; Liam J Murray; Brian J Reid; Wong-Ho Chow; Harvey A Risch; Olof Nyrén; Weimin Ye; Geoffrey Liu; Yvonne Romero; Leslie Bernstein; Anna H Wu; Alan G Casson; Stephen J Chanock; Patricia Harrington; Isabel Caldas; Irene Debiram-Beecham; Carlos Caldas; Nicholas K Hayward; Paul D Pharoah; Rebecca C Fitzgerald; Stuart Macgregor; David C Whiteman; Thomas L Vaughan
Journal:  Nat Genet       Date:  2013-10-13       Impact factor: 38.330

View more
  7 in total

1.  Association of sporadic and familial Barrett's esophagus with breast cancer.

Authors:  M Q Chan; A E Blum; A K Chandar; A M L Kieber Emmons; Y Shindo; W Brock; G W Falk; M I Canto; J S Wang; P G Iyer; N J Shaheen; W M Grady; J A Abrams; P N Thota; K K Guda; A Chak
Journal:  Dis Esophagus       Date:  2018-04-01       Impact factor: 3.429

Review 2.  Global burden and epidemiology of Barrett oesophagus and oesophageal cancer.

Authors:  Aaron P Thrift
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2021-02-18       Impact factor: 46.802

3.  The assembled and annotated genome of the masked palm civet (Paguma larvata).

Authors:  Ping Liu; Hai-Ying Jiang; Lin-Miao Li; Jia-Bin Zhou; Wen-Zhong Huang; Jin-Ping Chen
Journal:  Gigascience       Date:  2022-05-18       Impact factor: 7.658

Review 4.  Genomics, Endoscopy, and Control of Gastroesophageal Cancers: A Perspective.

Authors:  Brian J Reid
Journal:  Cell Mol Gastroenterol Hepatol       Date:  2017-02-20

Review 5.  V-Set and immunoglobulin domain containing (VSIG) proteins as emerging immune checkpoint targets for cancer immunotherapy.

Authors:  Xia Zhou; Sohail Khan; Dabing Huang; Lu Li
Journal:  Front Immunol       Date:  2022-09-15       Impact factor: 8.786

6.  Age of diagnosis in familial Barrett's associated neoplasia.

Authors:  Amitabh Chak; Andrew E Blum; Benita K Glamour; Omar Alaber; Gino Cioffi; Apoorva K Chandar; Jill Barnholtz-Sloan; Wendy Brock; Gary W Falk; Marcia I Canto; Jean S Wang; Prasad G Iyer; Nicholas J Shaheen; William M Grady; Julian A Abrams; Prashanthi N Thota
Journal:  Fam Cancer       Date:  2021-03-11       Impact factor: 2.446

7.  Esophageal Cancer: An Updated Surveillance Epidemiology and End Results Database Analysis.

Authors:  Eric Omar Then; Michell Lopez; Saad Saleem; Vijay Gayam; Tagore Sunkara; Andrea Culliford; Vinaya Gaduputi
Journal:  World J Oncol       Date:  2020-03-29
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.